Overview

Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The general objective of this study is to demonstrate the effectiveness of n-3 fatty acids, 2.4 grams per day, to prevent recurrence of atrial fibrillation in patients with paroxysmal or persistent AF in whom a rhythm-control strategy is planned.
Phase:
Phase 3
Details
Lead Sponsor:
Montreal Heart Institute